Literature DB >> 17607357

Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury.

Renzhi Han1, Dimple Bansal, Katsuya Miyake, Viviane P Muniz, Robert M Weiss, Paul L McNeil, Kevin P Campbell.   

Abstract

Dilated cardiomyopathy is a life-threatening syndrome that can arise from a myriad of causes, but predisposition toward this malady is inherited in many cases. A number of inherited forms of dilated cardiomyopathy arise from mutations in genes that encode proteins involved in linking the cytoskeleton to the extracellular matrix, and disruption of this link renders the cell membrane more susceptible to injury. Membrane repair is an important cellular mechanism that animal cells have developed to survive membrane disruption. We have previously shown that dysferlin deficiency leads to defective membrane resealing in skeletal muscle and muscle necrosis; however, the function of dysferlin in the heart remains to be determined. Here, we demonstrate that dysferlin is also involved in cardiomyocyte membrane repair and that dysferlin deficiency leads to cardiomyopathy. In particular, stress exercise disturbs left ventricular function in dysferlin-null mice and increases Evans blue dye uptake in dysferlin-deficient cardiomyocytes. Furthermore, a combined deficiency of dystrophin and dysferlin leads to early onset cardiomyopathy. Our results suggest that dysferlin-mediated membrane repair is important for maintaining membrane integrity of cardiomyocytes, particularly under conditions of mechanical stress. Thus, our study establishes what we believe is a novel mechanism underlying the cardiomyopathy that results from a defective membrane repair in the absence of dysferlin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17607357      PMCID: PMC1904311          DOI: 10.1172/JCI30848

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Contraction-induced cell wounding and release of fibroblast growth factor in heart.

Authors:  M S Clarke; R W Caldwell; H Chiao; K Miyake; P L McNeil
Journal:  Circ Res       Date:  1995-06       Impact factor: 17.367

2.  Insulin-dependent protein trafficking in skeletal muscle cells.

Authors:  M Zhou; L Sevilla; G Vallega; P Chen; M Palacin; A Zorzano; P F Pilch; K V Kandror
Journal:  Am J Physiol       Date:  1998-08

3.  Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy.

Authors:  F Muntoni; M Cau; A Ganau; R Congiu; G Arvedi; A Mateddu; M G Marrosu; C Cianchetti; G Realdi; A Cao
Journal:  N Engl J Med       Date:  1993-09-23       Impact factor: 91.245

4.  Limb-girdle muscular dystrophy 2C: clinical aspects.

Authors:  M Ben Hamida; C Ben Hamida; M Zouari; S Belal; F Hentati
Journal:  Neuromuscul Disord       Date:  1996-12       Impact factor: 4.296

5.  The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele.

Authors:  A Amalfitano; J S Chamberlain
Journal:  Muscle Nerve       Date:  1996-12       Impact factor: 3.217

6.  New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin.

Authors:  G A Cox; S F Phelps; V M Chapman; J S Chamberlain
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

7.  Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity.

Authors:  F Piccolo; S L Roberds; M Jeanpierre; F Leturcq; K Azibi; C Beldjord; A Carrié; D Récan; M Chaouch; A Reghis
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

8.  Dysferlin is a plasma membrane protein and is expressed early in human development.

Authors:  L V Anderson; K Davison; J A Moss; C Young; M J Cullen; J Walsh; M A Johnson; R Bashir; S Britton; S Keers; Z Argov; I Mahjneh; F Fougerousse; J S Beckmann; K M Bushby
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

9.  Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle.

Authors:  M S Clarke; R Khakee; P L McNeil
Journal:  J Cell Sci       Date:  1993-09       Impact factor: 5.285

10.  Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice.

Authors:  F Duclos; V Straub; S A Moore; D P Venzke; R F Hrstka; R H Crosbie; M Durbeej; C S Lebakken; A J Ettinger; J van der Meulen; K H Holt; L E Lim; J R Sanes; B L Davidson; J A Faulkner; R Williamson; K P Campbell
Journal:  J Cell Biol       Date:  1998-09-21       Impact factor: 10.539

View more
  86 in total

Review 1.  Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis.

Authors:  Alisa D Blazek; Brian J Paleo; Noah Weisleder
Journal:  Physiology (Bethesda)       Date:  2015-11

2.  Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in δ-Sarcoglycan-deficient hamsters.

Authors:  Bo He; Ru-hang Tang; Noah Weisleder; Bin Xiao; Zhenhua Yuan; Chuanxi Cai; Hua Zhu; Peihui Lin; Chunping Qiao; Jianbin Li; Christina Mayer; Juan Li; Jianjie Ma; Xiao Xiao
Journal:  Mol Ther       Date:  2012-02-07       Impact factor: 11.454

3.  Dysferlin, dystrophy, and dilatative cardiomyopathy.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2007-09-18       Impact factor: 4.599

Review 4.  Proteomics of the human placenta: promises and realities.

Authors:  J M Robinson; W E Ackerman; D A Kniss; T Takizawa; D D Vandré
Journal:  Placenta       Date:  2008-01-28       Impact factor: 3.481

5.  Membrane damage-induced vesicle-vesicle fusion of dysferlin-containing vesicles in muscle cells requires microtubules and kinesin.

Authors:  Joel R McDade; Daniel E Michele
Journal:  Hum Mol Genet       Date:  2013-11-07       Impact factor: 6.150

6.  Expression levels of sarcolemmal membrane repair proteins following prolonged exercise training in mice.

Authors:  Jenna Alloush; Steve R Roof; Eric X Beck; Mark T Ziolo; Noah Weisleder
Journal:  Indian J Biochem Biophys       Date:  2013-10       Impact factor: 1.918

7.  Placental proteomics: a shortcut to biological insight.

Authors:  J M Robinson; D D Vandré; W E Ackerman
Journal:  Placenta       Date:  2008-12-13       Impact factor: 3.481

8.  Limited proteolysis as a tool to probe the tertiary conformation of dysferlin and structural consequences of patient missense variant L344P.

Authors:  Natalie Woolger; Adam Bournazos; Reece A Sophocleous; Frances J Evesson; Angela Lek; Birgit Driemer; R Bryan Sutton; Sandra T Cooper
Journal:  J Biol Chem       Date:  2017-09-13       Impact factor: 5.157

9.  Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.

Authors:  Douglas P Millay; Marjorie Maillet; Joseph A Roche; Michelle A Sargent; Elizabeth M McNally; Robert J Bloch; Jeffery D Molkentin
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

10.  Calcium-dependent plasma membrane repair requires m- or mu-calpain, but not calpain-3, the proteasome, or caspases.

Authors:  Ronald L Mellgren; Katsuya Miyake; Irina Kramerova; Melissa J Spencer; Nathalie Bourg; Marc Bartoli; Isabelle Richard; Peter A Greer; Paul L McNeil
Journal:  Biochim Biophys Acta       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.